Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China
· Delayed Price · Currency is CNY 33.94
-1.93 (-5.38%)
Feb 28, 2025, 2:44 PM CST
SHA:603882 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 7,035 | 7,726 | 14,529 | 11,304 | 7,870 | 4,965 | Upgrade
|
| Other Revenue | 813.43 | 813.43 | 946.76 | 639.52 | 373.96 | 304.43 | Upgrade
|
| Revenue | 7,849 | 8,540 | 15,476 | 11,943 | 8,244 | 5,269 | Upgrade
|
| Revenue Growth (YoY) | -18.05% | -44.82% | 29.58% | 44.88% | 56.45% | 16.44% | Upgrade
|
| Cost of Revenue | 5,121 | 5,425 | 8,802 | 6,295 | 4,395 | 3,189 | Upgrade
|
| Gross Profit | 2,728 | 3,115 | 6,674 | 5,648 | 3,849 | 2,080 | Upgrade
|
| Selling, General & Admin | 1,637 | 1,730 | 2,506 | 2,323 | 1,613 | 1,288 | Upgrade
|
| Research & Development | 404.04 | 467.14 | 632.62 | 517.93 | 397.17 | 324.02 | Upgrade
|
| Other Operating Expenses | 53.28 | 14.91 | 14.75 | 11.71 | 6.93 | 6.31 | Upgrade
|
| Operating Expenses | 2,611 | 2,700 | 3,409 | 2,924 | 2,064 | 1,642 | Upgrade
|
| Operating Income | 116.69 | 414.93 | 3,266 | 2,724 | 1,785 | 437.85 | Upgrade
|
| Interest Expense | -19.26 | -20.39 | -23.65 | -27.55 | -29.26 | -37.64 | Upgrade
|
| Interest & Investment Income | 23.28 | 288.36 | 30.4 | 21.53 | 13.76 | 51.74 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.6 | -0.6 | 9.14 | -1.46 | -0.2 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.92 | -2.95 | -3.91 | -2.54 | -2.03 | -1.3 | Upgrade
|
| EBT Excluding Unusual Items | 134.03 | 679.35 | 3,278 | 2,714 | 1,767 | 450.65 | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.12 | - | -10.8 | -7.29 | -18.66 | -1.76 | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.46 | -7.57 | 2.97 | -10.11 | 1.43 | -0.16 | Upgrade
|
| Asset Writedown | -0.51 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 85.12 | 68.51 | 50.64 | 50.87 | 60.42 | 47 | Upgrade
|
| Pretax Income | 209.07 | 740.29 | 3,321 | 2,748 | 1,810 | 495.72 | Upgrade
|
| Income Tax Expense | 54.94 | 103.38 | 475.72 | 384.05 | 237.04 | 80.46 | Upgrade
|
| Earnings From Continuing Operations | 154.13 | 636.91 | 2,845 | 2,364 | 1,573 | 415.26 | Upgrade
|
| Minority Interest in Earnings | 7.08 | 6.47 | -90.22 | -143.87 | -63.73 | -12.93 | Upgrade
|
| Net Income | 161.2 | 643.38 | 2,755 | 2,220 | 1,510 | 402.33 | Upgrade
|
| Net Income to Common | 161.2 | 643.38 | 2,755 | 2,220 | 1,510 | 402.33 | Upgrade
|
| Net Income Growth | -81.73% | -76.64% | 24.11% | 47.03% | 275.24% | 72.44% | Upgrade
|
| Shares Outstanding (Basic) | 467 | 466 | 466 | 462 | 459 | 457 | Upgrade
|
| Shares Outstanding (Diluted) | 467 | 466 | 467 | 466 | 462 | 457 | Upgrade
|
| Shares Change (YoY) | -0.18% | -0.15% | 0.13% | 1.00% | 0.98% | -0.07% | Upgrade
|
| EPS (Basic) | 0.35 | 1.38 | 5.91 | 4.80 | 3.29 | 0.88 | Upgrade
|
| EPS (Diluted) | 0.35 | 1.38 | 5.90 | 4.76 | 3.27 | 0.88 | Upgrade
|
| EPS Growth | -81.70% | -76.61% | 23.95% | 45.57% | 271.59% | 72.55% | Upgrade
|
| Free Cash Flow | 532.47 | 516.07 | 1,107 | 1,136 | 972.45 | 386.47 | Upgrade
|
| Free Cash Flow Per Share | 1.14 | 1.11 | 2.37 | 2.44 | 2.11 | 0.85 | Upgrade
|
| Dividend Per Share | 0.880 | 0.880 | 1.780 | 1.280 | 0.329 | 0.136 | Upgrade
|
| Dividend Growth | -50.56% | -50.56% | 39.06% | 289.06% | 141.91% | 25.93% | Upgrade
|
| Gross Margin | 34.76% | 36.48% | 43.13% | 47.29% | 46.69% | 39.48% | Upgrade
|
| Operating Margin | 1.49% | 4.86% | 21.10% | 22.81% | 21.65% | 8.31% | Upgrade
|
| Profit Margin | 2.05% | 7.53% | 17.80% | 18.58% | 18.31% | 7.64% | Upgrade
|
| Free Cash Flow Margin | 6.78% | 6.04% | 7.15% | 9.51% | 11.80% | 7.33% | Upgrade
|
| EBITDA | 584.65 | 859.27 | 3,679 | 3,056 | 2,066 | 694.4 | Upgrade
|
| EBITDA Margin | 7.45% | 10.06% | 23.77% | 25.58% | 25.06% | 13.18% | Upgrade
|
| D&A For EBITDA | 467.96 | 444.34 | 412.85 | 331.56 | 280.85 | 256.55 | Upgrade
|
| EBIT | 116.69 | 414.93 | 3,266 | 2,724 | 1,785 | 437.85 | Upgrade
|
| EBIT Margin | 1.49% | 4.86% | 21.10% | 22.81% | 21.65% | 8.31% | Upgrade
|
| Effective Tax Rate | 26.28% | 13.96% | 14.33% | 13.98% | 13.09% | 16.23% | Upgrade
|
| Revenue as Reported | 7,849 | 8,540 | 15,476 | 11,943 | 8,244 | 5,269 | Upgrade
|
| Advertising Expenses | - | 2.16 | 3.29 | 3.16 | 2.71 | 1.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.